Association of apolipoprotein e genotype and cerebrovascular disease risk factors in a Turkish population

International Journal of Neuroscience

Volumn 118, Issue 8, 2008, Pages 1109-1129

  Tasdemir, Nebahat ^a   Tamam, Yusuf ^a   Toprak, Recep ^b   Tamam, Banu ^b   Tasdemir, M Serhan ^a  

^a DICLE UNIVERSITY   (Turkey)

^b Diyarbakir Devlet Hastanesi   (Turkey)

Author keywords

Apo E polymorphism; Hemorrhagic stroke; Ischemic stroke; Lipid profile; Risk factors; Turkish population

Indexed keywords

APOLIPOPROTEIN E; HOMOCYSTEIC ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POPULATION; PROTEIN LOCALIZATION; PROTEIN POLYMORPHISM; RISK FACTOR; STROKE; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTRACRANIAL HEMORRHAGES; LIPOPROTEINS, VLDL; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS; REFERENCE VALUES; RISK FACTORS; SEX FACTORS; STATISTICS, NONPARAMETRIC; STROKE; TRIGLYCERIDES;

EID: 46049104177     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.1080/00207450701769190     Document Type: Article

References (56)

1. Atilla, G., Acarturk, E., Eskandari, G., Akpinar, O., Tuli, A., Kanadasi, M., & Kayrin, L. (2001). Effects of apolipoprotein E genotypes and other risk factors on the development of coronary artery disease in Southern Turkey. Clinica Chimica Acta, 312, 191-196.
2. Bersot, T. P., Vega, G. L., Grundy, S. M., Palaoglu, K. E., Atagunduz, P., Ozbayrakci, S., Gokdemir, O., & Mahley, R. W. (1999). Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population. Journal of Lipid Research, 40, 432-438.
3. Bostom, A. G., Rosenberg, I. H., Silbershatz, H., Jacques, P. F., Selhub, J., D'Agostino, R. B., Wilson, P. W., & Wolf, P. A. (1999). Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: The Framingham study. Annals of Internal Medicine, 131, 352-355.
4. Boushey, C. J., Beresford, S. A., Omenn, G. S., & Motulsky, A. G. (1995). A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. Journal of the American Medical Association, 274, 1049-1057.
5. Brattstrom, L. E., Hardevo, J. E., & Hultverg, B. L. (1984). Moderate homocysteinemia - a possible risk factor for arteriosclerotic cerebrovasculardisease. Stroke, 15, 1012-1016.
6. Brega, A., Scacchi, R., Cuccia, M., Kirdar, B., Peloso, G., & Corbo, R. M. (1998). Study of 15 protein polymorphisms in a sample of the Turkish population. Human Biology, 70, 715-728.
7. Catto, A. J., McCormack, L. J., Mansfield, M. W., Carter, A. M., Bamford, J. M., Robinson, P., & Grant, P. J. (2000). Apolipoprotein E polymorphism in cerebrovascular disease. Acta Neurologica Scandinavia, 101,, 399-404.
8. Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalane, S., Fowler, B., & Graham, I. (1991). Hyperhomocysteinemia: An independent risk factor for vascular disease. New England Journal of Medicine, 324, 1149-1155.
9. Coria, F., Rubio, I., Nunez, E., Sempere, A. P., SantaEngarcia, N., Bayon, C., & Cuadrado, N. (1995). Apolipoprotein E variants in ischaemic stroke. Stroke, 26, 2375-2376.
10. Couderc, R., Mahieux, F., Bailleul, S., Fenelon, G., Mary, R., & Fermanian, J. (1993). Prevalence of apolipoprotein E phenotypes in ishemic cerebrovascular disease. A case-control study. Stroke, 24, 661-664.
11. Couderc, R., Mahieux, F., & Bailleul, S. (1994). Apolipoprotein E allele frequency in ishemic cerebrovascular disease and Alzheimer's disease. Stroke, 24, 1416-1417.
12. Dallongeville, J., Lussier-Cacan, S., & Davignon, J. (1992). Modulation of plasma triglyceride levels by apoE genotype: A meta-analysis. Journal of Lipid Research, 33, 447-454.
13. Di Carlo, A., Lamassa, M., Baldereschi, M., Pracucci, G., Consoli, D., Wolfe, C. D., Giroud, M., Rudd, A., Burger, I., Ghetti, A., Inzitari, D., & European BIOMED Study of Stroke Care Group. (2006). Risk factors and outcome of subtypes of ischemic stroke. Data from a multicenter multinational hospital-based registry. The European Community Stroke Project. Journal of the Neurological Sciences, 244, 143-150.
14. Dichgans, M., & Markus, H. S. (2005). Genetic association studies in stroke. Methodological issues and proposed standard criteria. Stroke , 36, 2027-2031.
15. Duzenli, S., Pirim, I., Gepdiremen, A., & Denizci, O. (2004). Apolipoprote?n E polymorphism and stroke in a population from eastern Turkey. Journal of Neurogenetics, 18, 365-375.
16. Fernandez-Miranda, C., Aranda, J. L., Martin, M. A., Arenas, J., Nunez, V., & Gomez dela Camara, A. (2004). Apolipoprotein E polymorphism and carotid atherosclerosis in patients with coronary disease. International Journal of Cardiology, 94, 209-212.
17. Flossmann, E., Schulz, U. G., & Rothwell, P. M. (2004). Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke, 35, 212-227.
18. Frank, A., Diez-Tejedo, E., Bullido, M. J., Valdivieso, F., & Barreiro, P. (2002). APOE genotype in cerebrovascular disease and vascular dementia. Journal of the Neurological Sciences, 203-204, 173-176.
19. Gensini, G. F., Comeglio, M., & Colella, A. (1998). Classical risk factors and emerging elements in the risk profile for coronary artery disease. European Heart Journal, 19, A53-61.
20. Gerdes, L. U., Klausen, I. C., Sihm, I., & Faergeman, O. (1992). Apolipoprotein E polymorphism in a Danish population compared findings in 45 other study populations around the world. Genetic Epidemiology, 9, 155-167.
21. Graffagnino, C., Gasecki, A. P., Dog, G. S., & Hachinski, V. C. (1994). The importance of family history in cerebrovascular disease. Stroke, 25, 1599-1604.
22. Hankey, G. J., Jamrozik, K., Broadhurst, R. J., Forbes, S., Burvill, P. W., Anderson, C. S., & Stewart-Wynne, E. G. (1998). Long-term risk of first recurrent stroke in the Perth Community Stroke Study. Stroke, 29, 2491-2500.
23. Hoggart, C. J., Parra, E. J., Shriver, M. D., Bonilla, C., Kittles, R. A., Clayton, D. G., & McKeigue, P. M. (2003). Control of confounding of genetic associations in stratified populations. American Journal of Human Genetics, 72, 1492-1500.
24. Kharrazi, H., Vaisi Raygani, A., Sabokroh, A. R., & Pourmotabbed, T. (2006). Association between apolipoprotein E polymorphism and coronary artery disease in the Kermanshah population in Iran. Clinical Biochemistry, 39, 613-616.
25. Kiely, D. K., Wolf, P. A., Cupples, L. A., Beiser, A. S., & Myrs, R. H. (1993). Familial aggregation of stroke: The Framingham study. Stroke, 24, 1366-1371.
26. Kim, J. S., Han, S. R., Chung, S. W., Kim, B. S., Lee, K. S., Kim, Y. I., Yang, D. W., Kim, K. S., & Kim, J. W. (2003). The apolipoprotein E epsilon4 haplotype is an important predictor for recurrence in ischemic cerebrovascular disease. Journal of Neurological Sciences, 206, 3-5.
27. Kuusisto, J., Mykkanen, L., Kervinen, K., Kesaniemi, Y. A., & Laakso, M. (1995). Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arteriosclerosis, Thrombosis, and Vascular Biology, 15, 1280-1286.
28. Lehtinen, S., Luoma, P., Lehtimaki, T., Nayha, S., Hassi, J., & Nikkari, T. (1994). Differences in genetic variations of apolipoprotein E in Lapps and Finns. Atherosclerosis, 109, 263-268.
29. Letonja, M., Guzic-Salobir, B., Peterlin, B., & Petrovic, D. (2004). Apolipoprotein E gene polymorphism effects triglycerides but not CAD risk in Caucasian women younger than 65 years. Annales De Génétique, 47, 147-153.
30. Luc, G., Bard, J. M., Arveiler, D., Evans, A., Cambou, J. P., Bingham, A., Amouyel, P., Schaffer, P., Ruidavets, J. B., & Cambien, F. (1994). Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM study. Arteriosclerosis and Thrombosis, 14, 1412-1419.
31. Mahley, R. W., Palaoglu, K. E., Atak, Z., Dawson-Pepin, J., Langlois, A. M., Cheung, V., Onat, H., Fulks, P., Mahley, L. L., & Vakar, F. (1995). Turkish heart study: Lipids, lipoproteins, and apolipoproteins. Journal of Lipid Research, 36, 839-859.
32. Manke, C., Schuster, H., Keller, C., & Wolfram, G. (1993). The effect of the apolipoprotein E polymorphism on lipid levels in patients with familial defective apolipoprotein B-100. The Clinical Investigator, 71, 277-280.
33. Moroney, J. T., Bagiella, E., Paik, M. C., Sacco, R. L., & Desmond, D. W. (1998). Risk factors for early recurrence after ischemic stroke: The role of stroke syndrome and subtype. Stroke, 29, 2118-2124.
34. Nakata, Y., Katsuya, T., Rakugi, H., Takami, S., Sato, N., Kamide, K., Ohishi, M., Miki, T., Higaki, J., & Ogihara, T. (1997). Polymorphism of angiotensin converting enzyme, angiotensinogen, and apolipoprotein E genes in a Japanese population with cerebrovascular disease. American Journal of Hypertension, 10, 1391-1395.
35. Nathan, B. P., Bellosta, S., Sanan, D. A., Weisgraber, K. H., Mahley, R. W., & Pitas, R. E. (1994). Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science, 264, 850-852.
36. Pedro-Botet, J., Senti, M., Nogues, X., Rubies-Prat, J., Roquer, J., D'Olhaberriague, L., & Olive, J. (1992). Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke, 23, 1556-1562.
37. Poirier, J. (1994). Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends in Neurosciences, 17, 525-530.
38. Prencipe, M., Culasso, F., Rasura, M., Anzini, A., Beccia, M., Cao, M., Giubilei, F., & Fieschi, C. (1998). Long-term prognosis after a minor stroke: 10-year mortality and major stroke recurrence rates in a hospital-based cohort. Stroke, 29, 126-132.
39. Roses, A., Strittmatter, W., Saunders, A., Schmechel, D., & Pericak-Vance, M. (1996). Apolipoprotein E and Alzheimer's disease: State of the field after two years. In A. Roses, K. Weisgraber, & Y. Christen (Eds.), Apolipoprotein E and Alzheimer's Disease. (pp. 1-10). Berlin: Springer.
40. Roses, A. D. (1997). Apolipoprotein E, a gene with complex biological interactions in the aging brain. Neurobiology of Disease, 4, 170-186.
41. Rubattu, S., Gigante, B., Stanzione, R., De Paolis, P., Tarasi, D., & Volpe, M. (2004). In the search for stroke genes: A long and winding road. American Journal of Hypertension, 17, 197-202.
42. Saunders, A. M., & Roses, A. D. (1993). Apolipoprotein E allele frequency, ishemic cerebrovascular deisease, and Alzheimer's disease. Stroke, 24, 1416-1417.
43. Schulz, U. GR., Flossmann, E., & Rothwell, P. M. (2004). Heritability of ischemic stroke in relation to age, vascular risk factors, and subtypes of incident stroke in population-based studies. Stroke, 35, 819-824.
44. Shinton, R., & Beever, G. (1989). Meta-analysis of relation between cigarette smoking and stroke. British Medical Journal, 298, 789-794.
45. Sing, C. F., & Davignon, J. (1985). Role of the apolipoprotein E polymorphismin determining normal plasma lipid and lipoprotein variation. American Journal of Human Genetics, 37, 268-285.
46. Sklavounou, E., Economou-Petersen, E., Karadima, G., Panas, M., Avramopoulos, D., Varsou,, A., Vassilopoulos, D., & Petersen, M. B. (1997). Apolipoprotein E polymorphism in the Greek population. Clinical Genetics, 52, 216-218.
47. Srinivasan, S. R., Ehnholm, C., Elkasabany, A., & Berenson, G. (1999). Influence of apolipoprotein E polymorphism on serum lipids and lipoprotein changes from childhood to adulthood. The Bogalusa Heart Study. Atherosclerosis, 143, 435-443.
48. Tan, C. E., Tai, E. S., Tan, C. S., Chia, K. S., Lee, J., Chew, S. K., & Ordovas, J. M. (2003). APOE polymorphism and lipid profile in three ethnic groups in the Singapore population. Atherosclerosis, 170, 253-260.
49. Tanaka, H., Ueda, Y., Hayashi, M., Date, C., Baba, T., Yamashita, H., Shoji, H., Tanaka, Y., Owada, K., & Detels, R. (1982). Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community. Stroke, 13, 62-73.
50. Tang, J., Zhao, J., Zhao, Y., Wang, S., Chen, B., & Zeng, W. (2003). Apolipoprotein E epsilon 4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage. Surgical Neurology, 60, 391-396.
51. Tiret, L., de-Knijff, P., Menzel, H. J., Ehnhollm, C., Nicaud, V., & Havekes, L. M. (1994). ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS study. European atherosclerosis research study. Arteriosclerosis and Thrombosis, 14, 1617-1624.
52. Tonk, M., & Haan, J. (2007). A review of genetic causes of ischemic and hemorrhagic stroke. Journal of the Neurological Sciences, 257, 273-279.
53. Wilson, W. F., Myers, R. H., Darson, M. G., Ordovas, J. M., Wolf, P. A., & Schaefer, E. J. (1994). Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. Journal of the American Medical Association, 272, 1666-1671.
54. Woo, D., Sauerbeck, L. R., Kissela, B. M., Khoury, J. C., Szaflarski, J. P., Gebel, J., Shukla, R., Pancioli, A. M., Jauch, E. C., Menon, A. G., Deka, R., Carrozzella, J. A., Moomaw, C. J., Fontaine, R. N., & Broderick, J. P. (2002). Genetic and environmental risk factors for intracerebral hemorrhage. Preliminary results of a population-based study. Stroke, 33, 1190-1196.
55. XuGuang, G., Yang, H., & Zhiping, T. (2006). Association studies of genetic polymorphism, environmental factors and their interaction in ischemic stroke. Neuroscience Letters, 398, 172-177.
56. Yoo, J. H., Chung, C. S., & Kang, S. S. (1998). Relation of plasma homocysteine to cerebral infarction and cerebral atherosclerosis. Stroke, 29, 2478-2483.